Table: begin end state 1 22 cytoplasmic 23 44 transmembrane 45 50 non-cytoplasmic 51 70 transmembrane 71 99 cytoplasmic 100 122 transmembrane 123 127 non-cytoplasmic 128 148 transmembrane 149 157 cytoplasmic 158 182 transmembrane 183 201 non-cytoplasmic 202 224 transmembrane 225 242 cytoplasmic 243 264 transmembrane 265 283 non-cytoplasmic 284 305 transmembrane 306 325 cytoplasmic 326 350 transmembrane 351 361 non-cytoplasmic 362 385 transmembrane 386 404 cytoplasmic 405 424 transmembrane 425 429 non-cytoplasmic 430 449 transmembrane 450 459 cytoplasmic
Input: >WP_058932055.1 NCBI__GCF_001484605.1:WP_058932055.1 MTSKSTAVRPESHLGHTMKPRQLTMMGLGSAIGAGLFLGSGAGIQAAGPAVLISYLVAGT LIILVMWALGEMAAANPTSGAFSVYAERALGKTAGATVGWLWWLQLVVVIAAEALGAAGL LFSVWPAIPVWALALTFMVVFTAINLTGVKNFGEFEFWFAILKVAAIVAFLAVGAALLLG LLPDVASPGLANITTDFAPAGLGGVATALFVVIFAFGGTEIVAVAAAETEDPEHSVGKAI RTVLWRILVFYIGSVFVIAAVLPVSSEGLASPFAGVLDAARIPGAGTAITLVAVVALLSA LNANLYGASRMVYSLAERGEAPRFLARLSGASVPMLAVGVSVAFGFFATVLELLFPDRIL PALFQLVGSTCLVVWGTALVSQLILRRRADREGAELPLRMKGFPGLTICGLVLLGLIFAI GFSAESSRGQLLSTFVLVACLAAACWLGARLTTRDRQPK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server